RBC Bearings INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that RBC Bearings INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $1.64B | May 16, 2025 |
| FY2025 | Mar 30, 2024 | $1.56B | May 16, 2025 |
| FY2025 | Apr 1, 2023 | $1.47B | May 16, 2025 |
| FY2022 | Apr 30, 2022 | $942.94M | Aug 5, 2022 |
| FY2024 | Apr 2, 2022 | $942.90M | May 17, 2024 |
| FY2022 | Apr 30, 2021 | $608.98M | Aug 5, 2022 |
| FY2022 | Apr 3, 2021 | $608.98M | May 26, 2022 |
| FY2022 | Mar 28, 2020 | $727.46M | Aug 5, 2022 |
| FY2021 | Mar 30, 2019 | $702.52M | May 21, 2021 |
| FY2019 | Mar 31, 2018 | $674.95M | May 23, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Mar 31, 2018 | $674.95M | May 30, 2018 |
| FY2018 | Apr 1, 2017 | $615.39M | May 30, 2018 |
| FY2018 | Apr 2, 2016 | $597.47M | May 30, 2018 |
| FY2017 | Mar 28, 2015 | $445.28M | May 31, 2017 |
| FY2016 | Mar 29, 2014 | $418.89M | May 26, 2016 |
| FY2015 | Mar 30, 2013 | $403.05M | May 27, 2015 |
| FY2013 | Mar 31, 2012 | $397.51M | May 28, 2014 |
| FY2012 | Apr 2, 2011 | $335.63M | May 29, 2013 |
| FY2011 | Apr 3, 2010 | $274.70M | May 30, 2012 |
| FY2010 | Mar 28, 2009 | $355.80M | May 27, 2011 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $726.10M | May 16, 2025 |
| FY2025 | Mar 30, 2024 | $670.50M | May 16, 2025 |
| FY2025 | Apr 1, 2023 | $604.80M | May 16, 2025 |
| FY2022 | Apr 30, 2022 | $357.07M | Aug 5, 2022 |
| FY2024 | Apr 2, 2022 | $357.10M | May 17, 2024 |
| FY2022 | Apr 30, 2021 | $234.11M | Aug 5, 2022 |
| FY2022 | Apr 3, 2021 | $234.11M | May 26, 2022 |
| FY2022 | Mar 28, 2020 | $289.10M | Aug 5, 2022 |
| FY2021 | Mar 30, 2019 | $276.65M | May 21, 2021 |
| FY2019 | Mar 31, 2018 | $258.54M | May 23, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $246.20M | May 16, 2025 |
| FY2025 | Mar 30, 2024 | $209.90M | May 16, 2025 |
| FY2025 | Apr 1, 2023 | $166.70M | May 16, 2025 |
| FY2024 | Apr 2, 2022 | $54.70M | May 17, 2024 |
| FY2022 | Apr 3, 2021 | $89.63M | May 26, 2022 |
| FY2022 | Mar 28, 2020 | $120.35M | Aug 5, 2022 |
| FY2021 | Mar 30, 2019 | $105.19M | May 21, 2021 |
| FY2019 | Mar 31, 2018 | $87.14M | May 23, 2019 |
| FY2019 | Apr 1, 2017 | $70.62M | May 23, 2019 |
| FY2018 | Apr 2, 2016 | $63.89M | May 30, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $369.90M | May 16, 2025 |
| FY2025 | Mar 30, 2024 | $342.20M | May 16, 2025 |
| FY2025 | Apr 1, 2023 | $293.00M | May 16, 2025 |
| FY2024 | Apr 2, 2022 | $121.10M | May 17, 2024 |
| FY2022 | Apr 3, 2021 | $111.46M | May 26, 2022 |
| FY2022 | Mar 28, 2020 | $149.37M | Aug 5, 2022 |
| FY2021 | Mar 30, 2019 | $132.04M | May 21, 2021 |
| FY2019 | Mar 31, 2018 | $128.77M | May 23, 2019 |
| FY2019 | Apr 1, 2017 | $114.59M | May 23, 2019 |
| FY2018 | Apr 2, 2016 | $103.84M | May 30, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $33.00M | May 16, 2025 |
| FY2025 | Mar 30, 2024 | $33.00M | May 16, 2025 |
| FY2025 | Apr 1, 2023 | $31.80M | May 16, 2025 |
| FY2024 | Apr 2, 2022 | $27.60M | May 17, 2024 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $279.30M | May 16, 2025 |
| FY2025 | Mar 30, 2024 | $253.50M | May 16, 2025 |
| FY2025 | Apr 1, 2023 | $229.70M | May 16, 2025 |
| FY2024 | Apr 2, 2022 | $167.60M | May 17, 2024 |
| FY2022 | Apr 3, 2021 | $106.00M | May 26, 2022 |
| FY2022 | Mar 28, 2020 | $129.98M | Aug 5, 2022 |
| FY2021 | Mar 30, 2019 | $117.50M | May 21, 2021 |
| FY2019 | Mar 31, 2018 | $113.12M | May 23, 2019 |
| FY2019 | Apr 1, 2017 | $102.92M | May 23, 2019 |
| FY2018 | Apr 2, 2016 | $98.72M | May 30, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $293.60M | May 16, 2025 |
| FY2025 | Mar 30, 2024 | $274.70M | May 16, 2025 |
| FY2025 | Apr 1, 2023 | $220.60M | May 16, 2025 |
| FY2024 | Apr 2, 2022 | $180.30M | May 17, 2024 |
| FY2022 | Apr 3, 2021 | $152.45M | May 26, 2022 |
| FY2022 | Mar 28, 2020 | $155.62M | Aug 5, 2022 |
| FY2021 | Mar 30, 2019 | $108.55M | May 21, 2021 |
| FY2019 | Mar 31, 2018 | $130.29M | May 23, 2019 |
| FY2019 | Apr 1, 2017 | $101.24M | May 23, 2019 |
| FY2018 | Apr 2, 2016 | $83.36M | May 30, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Apr 1, 2023 | $42.00M | May 19, 2023 |
| FY2022 | Apr 30, 2022 | $29.76M | Aug 5, 2022 |
| FY2023 | Apr 2, 2022 | $29.80M | May 19, 2023 |
| FY2022 | Apr 30, 2021 | $11.77M | Aug 5, 2022 |
| FY2022 | Apr 3, 2021 | $11.77M | May 26, 2022 |
| FY2022 | Mar 28, 2020 | $37.30M | Aug 5, 2022 |
| FY2021 | Mar 30, 2019 | $41.35M | May 21, 2021 |
| FY2019 | Mar 31, 2018 | $27.98M | May 23, 2019 |
| FY2019 | Apr 1, 2017 | $20.89M | May 23, 2019 |
| FY2018 | Apr 2, 2016 | $20.86M | May 30, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $4.69B | May 16, 2025 |
| FY2025 | Mar 30, 2024 | $4.68B | May 16, 2025 |
| FY2025 | Apr 1, 2023 | $4.69B | May 16, 2025 |
| FY2022 | Apr 30, 2022 | $4.85B | Aug 5, 2022 |
| FY2023 | Apr 2, 2022 | $4.85B | May 19, 2023 |
| FY2022 | Apr 30, 2021 | $1.43B | Aug 5, 2022 |
| FY2022 | Apr 3, 2021 | $1.43B | Aug 5, 2022 |
| FY2022 | Mar 28, 2020 | $1.32B | Aug 5, 2022 |
| FY2021 | Mar 30, 2019 | $1.15B | May 21, 2021 |
| FY2020 | Mar 31, 2018 | $1.14B | May 20, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $1.65B | May 16, 2025 |
| FY2025 | Mar 30, 2024 | $1.93B | May 16, 2025 |
| FY2024 | Apr 1, 2023 | $2.15B | May 17, 2024 |
| FY2023 | Apr 2, 2022 | $2.47B | May 19, 2023 |
| FY2022 | Apr 3, 2021 | $202.16M | Aug 5, 2022 |
| FY2021 | Mar 28, 2020 | $203.91M | May 21, 2021 |
| FY2020 | Mar 30, 2019 | $178.80M | May 20, 2020 |
| FY2019 | Mar 31, 2018 | $308.20M | May 23, 2019 |
| FY2018 | Apr 1, 2017 | $391.80M | May 30, 2018 |
| FY2017 | Apr 2, 2016 | $477.56M | May 31, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $3.03B | May 16, 2025 |
| FY2025 | Mar 30, 2024 | $2.75B | May 16, 2025 |
| FY2025 | Apr 1, 2023 | $2.54B | May 16, 2025 |
| FY2025 | Apr 2, 2022 | $2.37B | May 16, 2025 |
| FY2024 | Apr 3, 2021 | $1.23B | May 17, 2024 |
| FY2023 | Mar 28, 2020 | $1.12B | May 19, 2023 |
| FY2022 | Mar 30, 2019 | $971.69M | Aug 5, 2022 |
| FY2021 | Mar 31, 2018 | $834.55M | May 21, 2021 |
| FY2018 | Apr 1, 2017 | $717.04M | May 30, 2018 |
| FY2020 | Mar 31, 2017 | $717.04M | May 20, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $1.87B | May 16, 2025 |
| FY2025 | Mar 30, 2024 | $1.87B | May 16, 2025 |
| FY2024 | Apr 1, 2023 | $1.87B | May 17, 2024 |
| FY2023 | Apr 2, 2022 | $1.90B | May 19, 2023 |
| FY2022 | Apr 3, 2021 | $277.54M | Aug 5, 2022 |
| FY2021 | Mar 28, 2020 | $277.78M | May 21, 2021 |
| FY2020 | Aug 15, 2019 | $15.96M | May 20, 2020 |
| FY2020 | Mar 30, 2019 | $261.43M | May 20, 2020 |
| FY2019 | Mar 31, 2018 | $268.12M | May 23, 2019 |
| FY2018 | Apr 1, 2017 | $268.04M | May 30, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $1.45B | May 16, 2025 |
| FY2025 | Mar 30, 2024 | $1.22B | May 16, 2025 |
| FY2024 | Apr 1, 2023 | $1.03B | May 17, 2024 |
| FY2023 | Apr 2, 2022 | $886.10M | May 19, 2023 |
| FY2022 | Apr 3, 2021 | $843.46M | Aug 5, 2022 |
| FY2022 | Mar 28, 2020 | $10.22M | Aug 5, 2022 |
| FY2020 | Mar 30, 2019 | $641.89M | May 20, 2020 |
| FY2019 | Mar 31, 2018 | $536.98M | May 23, 2019 |
| FY2018 | Apr 1, 2017 | $448.69M | May 30, 2018 |
| FY2017 | Apr 2, 2016 | $378.07M | May 31, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $36.80M | May 16, 2025 |
| FY2025 | Mar 30, 2024 | $63.50M | May 16, 2025 |
| FY2024 | Apr 1, 2023 | $65.40M | May 17, 2024 |
| FY2023 | Apr 2, 2022 | $182.90M | May 19, 2023 |
| FY2022 | Apr 3, 2021 | $151.09M | Aug 5, 2022 |
| FY2021 | Mar 28, 2020 | $103.26M | May 21, 2021 |
| FY2021 | Mar 30, 2019 | $29.88M | May 21, 2021 |
| FY2021 | Mar 31, 2018 | $54.16M | May 21, 2021 |
| FY2019 | Apr 1, 2017 | $38.92M | May 23, 2019 |
| FY2020 | Mar 31, 2017 | $38.92M | May 20, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | $920.10M | May 16, 2025 |
| FY2025 | Mar 30, 2024 | $1.19B | May 16, 2025 |
| FY2023 | Apr 1, 2023 | $1.39B | May 19, 2023 |
| FY2023 | Apr 2, 2022 | $1.69B | May 19, 2023 |
| FY2022 | Apr 3, 2021 | $16.11M | Aug 5, 2022 |
| FY2021 | Mar 28, 2020 | $23.01M | May 21, 2021 |
| FY2020 | Mar 30, 2019 | $43.65M | May 20, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | 7 | May 16, 2025 |
| FY2025 | Mar 30, 2024 | 6 | May 16, 2025 |
| FY2025 | Apr 1, 2023 | 5 | May 16, 2025 |
| FY2024 | Apr 2, 2022 | 1 | May 17, 2024 |
| FY2022 | Apr 3, 2021 | 3 | May 26, 2022 |
| FY2022 | Mar 28, 2020 | 4 | Aug 5, 2022 |
| FY2021 | Mar 30, 2019 | 4 | May 21, 2021 |
| FY2019 | Mar 31, 2018 | 3 | May 23, 2019 |
| FY2019 | Apr 1, 2017 | 3 | May 23, 2019 |
| FY2018 | Apr 2, 2016 | 2 | May 30, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | 7 | May 16, 2025 |
| FY2025 | Mar 30, 2024 | 6 | May 16, 2025 |
| FY2025 | Apr 1, 2023 | 4 | May 16, 2025 |
| FY2024 | Apr 2, 2022 | 1 | May 17, 2024 |
| FY2022 | Apr 3, 2021 | 3 | May 26, 2022 |
| FY2022 | Mar 28, 2020 | 4 | Aug 5, 2022 |
| FY2021 | Mar 30, 2019 | 4 | May 21, 2021 |
| FY2019 | Mar 31, 2018 | 3 | May 23, 2019 |
| FY2019 | Apr 1, 2017 | 2 | May 23, 2019 |
| FY2018 | Apr 2, 2016 | 2 | May 30, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 29, 2025 | 32.52M | May 16, 2025 |
| FY2025 | Mar 30, 2024 | 30.23M | May 16, 2025 |
| FY2020 | Mar 28, 2020 | 25.88M | May 20, 2020 |
| FY2020 | Mar 30, 2019 | 25.61M | May 20, 2020 |
| FY2018 | Mar 31, 2018 | 24.11M | May 30, 2018 |
| FY2018 | Apr 1, 2017 | 23.77M | May 30, 2018 |
| FY2017 | Apr 2, 2016 | 24.15M | May 31, 2017 |
| FY2016 | Mar 28, 2015 | 23.83M | May 26, 2016 |
| FY2015 | Mar 29, 2014 | 23.52M | May 27, 2015 |
| FY2013 | Mar 30, 2013 | 23.28M | May 28, 2014 |